Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors - Top-Institutions - MDSpire

Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors

  • By

  • Masashi Kubota

  • Satomi Yoshida

  • Takayuki Goto

  • Toshiki Fukasawa

  • Takayuki Anno

  • Gaku Fujiwara

  • Satoshi Toshiyama

  • Yoshihide Inayama

  • Takanori Yanai

  • Takayuki Sumiyoshi

  • Ryoichi Saito

  • Takashi Kobayashi

  • Koji Kawakami

  • January 16, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Cardiology
    • Surgical Oncology
    • Hematology
    • Minimally Invasive Surgery

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Surgical Oncology
    • Perioperative Medicine

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Surgical Oncology
    • Minimally Invasive Surgery
    • Hematology

  • #4

    Brigham and Women's Hospital
    Brigham and Women's Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Surgical Oncology
    • Perioperative Medicine

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Surgical Oncology
    • Minimally Invasive Surgery

Original Source(s)

Impact of Preoperative Suspension of Antiplatelet Therapy on Thrombotic Events Following Minimally Invasive Surgery for Abdominopelvic Cancer in Patients Using P2Y12 Inhibitors

  • by Masashi Kubota, Satomi Yoshida, Takayuki Goto, Toshiki Fukasawa, Takayuki Anno, Gaku Fujiwara, Satoshi Toshiyama, Yoshihide Inayama, Takanori Yanai, Takayuki Sumiyoshi, Ryoichi Saito, Takashi Kobayashi, Koji Kawakami

  • January 16, 2026

Related Content

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research